Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02824016Completed
Open-label trial (2 arms), sponsored by Institut Godinot. Primary endpoint: Number of patients with treatment-related adverse effects on thyroid function at 60 months. Started Feb 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02824016.